T cell immunity to biliary epithelial antigen in primary biliary cirrhosis.
T cell immunity to biliary epithelial antigen in primary biliary cirrhosis.
批准号:
04670433
负责人:
ONISHI Saburo
金额:
$1.02万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993
中文摘要
原发性胆汁性肝硬化中,人胆道抗原p28可刺激外周血T淋巴细胞。通过尸检原发性胆汁性肝硬化患者的微细胞毒性实验也证实脾T淋巴细胞对自体胆道上皮细胞具有细胞毒性。HLAⅱ类基因DNA分型显示DRBl^<**>0803是与本病发生相关的HLAⅱ类基因之一。另一方面,HLA i类肿瘤坏死因子- α基因(tnf - α / Ncol RFLP, 5.5kb)和转运蛋白基因(Tap2/Ringll)与疾病无相关性。有趣的是,与DRBl^<**>0803阴性患者相比,p28对DRBl^<**>0803阳性患者T淋巴细胞的刺激更强烈。综上所述,p28可能是参与原发性胆汁性肝硬化发病机制的靶抗原之一。虽然p28的内部氨基酸序列尚未确定,但分析p28与t细胞受体和DRBl^<**>0803的相互作用对了解胆管损伤的机制具有重要意义。
英文摘要
In primary biliary cirrhosis, human biliary antigen p28 can stimulate peripheral blood T lymphocytes. It was also demonstrated that splenic T lymphocytes were cytotoxicic against autologous biliary epithelial cells by microcytotoxicity assay in autopsy patients with primary biliary cirrhosis.DNA typing of HLA class II genes showed that DRBl^<**>0803 is one of HLA class II genes related to the development of the disease. On the other hand, HLA class I.tumor necrosis factor-alpha genes(RFLP of TNF-alpha/ Ncol, 5.5kb) and transportor gene( Tap2/Ringll) are not associated with the disease.Interretingly, T Iymphocytes of DRBl^<**>0803 positive patients more strongly stimulated with p28, in comparison with DRBl^<**>0803 negative patients.In conclusion, p28 may be one of target antigens involved in the pathogenesis of primary biliary cirrhosis. Although inner amino asid sequense of p28 is not determined, analysis of interaction between p28, Tcell receptor and DRBl^<**>0803 is important in understanding the mechanism of biliary duct injury.
期刊论文(57)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
大西三朗: "自己免疫性肝炎" 日本医学館, 81 (1992)
大西三郎:“自身免疫性肝炎”日本医学博物馆,81(1992)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Onishi: "Cytotoxic activity of spleen-derived T lymphoytes against autologous biliary epithelical cells in autopsy patients with primary biliary" Liver. 13. 188-192 (1993)
S.Onishi:“原发性胆道肝脏尸检患者中脾源性 T 淋巴细胞对自体胆道上皮细胞的细胞毒性活性”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Onishi: "Assessment of LAK activity andgamma-interferon producture in patients with small hepatocellular carcinomas" Hepatology. 17. 781-787 (1993)
S.Onishi:“小肝细胞癌患者 LAK 活性和γ-干扰素产物的评估”肝病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
大西三朗: "1993 今日の治療指針" 医学書院, (1993)
大西三郎:“1993 年今天的治疗指南”Igakushoin,(1993)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiromi Himeno: "Administration of 1L-2 induces MHC classII expression on the biliary epithelial cello,possibly Hrrough endogenous interferon-γ production." Hepatology. 16. 409-417 (1992)
Hiromi Himeno:“施用 1L-2 会诱导胆管上皮细胞上的 MHC II 类表达,可能是通过内源性干扰素-γ 产生。” 16. 409-417 (1992)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 28 条
Primary biliary cirrhosis and estrogen-mediated regulation of CD4+CD25+ thymocyte differentiation.
-
批准号:15590657
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:ONISHI Saburo
-
依托单位:
Modulation of thymocyte development by estrogen and autoimmune hepatitis
-
批准号:13670525
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2001
-
负责人:ONISHI Saburo
-
依托单位:
PRES1 CONTRIBUTES IN HEPATOCARCINOGENESIS IN PATIENTS WITH HBV INFECTION
-
批准号:11670510
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:ONISHI Saburo
-
依托单位:
Autoimmune-mediated mechanism of biliary injury in primary biliary cirrhosis
-
批准号:07457596
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$0.32万
-
财政年份:1995
-
负责人:ONISHI Saburo
-
依托单位:
Purification of Human Biliary Epithelial Antigen and T Cell Autoimmunity in Patients with Primary biliary Cirrchosis
-
批准号:01570404
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:1989
-
负责人:ONISHI Saburo
-
依托单位:
Autoimmunity to Bile Duct Epithelial Cells in Patients with Primary Billary Cirrhosis
-
批准号:62570329
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:1987
-
负责人:ONISHI Saburo
-
依托单位:
海外基金